Patent · US Expired

Dipeptidyl peptidase IV inhibitors and their uses as anti-cancer agents

US7109347B2 · kind B2 · utility

8Cited by

30References

5Claims

0Family size

Assignee

PROBIODRUG AG · DE

Inventors

Stephan von Hoersten · Großburgwedel, DE
Hans-Ulrich Demuth · Halle (Saale), DE
Torsten Hoffmann · Weil am Rhein, DE

Key dates

Filing date	Mar 30, 2005
Grant date	Sep 19, 2006
Priority date	—
Expiry date	Mar 30, 2025

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/55
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides new uses of DPIV-inhibitors of the present invention, and their corresponding pharmaceutically acceptable acid addition salt forms, for treating conditions mediated by DPIV or DPIV-like enzymes, such as cancer and tumors. In a more preferred embodiment, the compounds of the present invention are useful for the treatment of metastasis and tumor colonization.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.